These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 38907038)
1. Prediction of O(6)-methylguanine-DNA methyltransferase promoter methylation status in IDH-wildtype glioblastoma using MRI histogram analysis. Liu X; Han T; Wang Y; Liu H; Zhou J Neurosurg Rev; 2024 Jun; 47(1):285. PubMed ID: 38907038 [TBL] [Abstract][Full Text] [Related]
2. O Alassiri AH; Alkhaibary A; Al-Sarheed S; Alsufani F; Alharbi M; Alkhani A; Aloraidi A Ann Saudi Med; 2019; 39(6):410-416. PubMed ID: 31804140 [TBL] [Abstract][Full Text] [Related]
3. Non-invasive prediction of p53 and Ki-67 labelling indices and O-6-methylguanine-DNA methyltransferase promoter methylation status in adult patients with isocitrate dehydrogenase wild-type glioblastomas using diffusion-weighted imaging and dynamic susceptibility contrast-enhanced perfusion-weighted imaging combined with conventional MRI. Xing Z; Huang W; Su Y; Yang X; Zhou X; Cao D Clin Radiol; 2022 Aug; 77(8):e576-e584. PubMed ID: 35469666 [TBL] [Abstract][Full Text] [Related]
4. Radiomics and MGMT promoter methylation for prognostication of newly diagnosed glioblastoma. Sasaki T; Kinoshita M; Fujita K; Fukai J; Hayashi N; Uematsu Y; Okita Y; Nonaka M; Moriuchi S; Uda T; Tsuyuguchi N; Arita H; Mori K; Ishibashi K; Takano K; Nishida N; Shofuda T; Yoshioka E; Kanematsu D; Kodama Y; Mano M; Nakao N; Kanemura Y Sci Rep; 2019 Oct; 9(1):14435. PubMed ID: 31594994 [TBL] [Abstract][Full Text] [Related]
5. Prediction of methylguanine methyltransferase promoter methylation in glioblastoma using dynamic contrast-enhanced magnetic resonance and diffusion tensor imaging. Ahn SS; Shin NY; Chang JH; Kim SH; Kim EH; Kim DW; Lee SK J Neurosurg; 2014 Aug; 121(2):367-73. PubMed ID: 24949678 [TBL] [Abstract][Full Text] [Related]
6. Choi HJ; Choi SH; You SH; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH; Park CK; Park SH AJNR Am J Neuroradiol; 2021 May; 42(5):853-860. PubMed ID: 33632732 [TBL] [Abstract][Full Text] [Related]
7. Different diagnostic values of imaging parameters to predict pseudoprogression in glioblastoma subgroups stratified by MGMT promoter methylation. Yoon RG; Kim HS; Paik W; Shim WH; Kim SJ; Kim JH Eur Radiol; 2017 Jan; 27(1):255-266. PubMed ID: 27048531 [TBL] [Abstract][Full Text] [Related]
8. Discriminating MGMT promoter methylation status in patients with glioblastoma employing amide proton transfer-weighted MRI metrics. Jiang S; Rui Q; Wang Y; Heo HY; Zou T; Yu H; Zhang Y; Wang X; Du Y; Wen X; Chen F; Wang J; Eberhart CG; Zhou J; Wen Z Eur Radiol; 2018 May; 28(5):2115-2123. PubMed ID: 29234914 [TBL] [Abstract][Full Text] [Related]
9. The diagnostic value of ADC histogram and direct ADC measurements for coexisting isocitrate dehydrogenase mutation and O6-methylguanine-DNA methyltransferase promoter methylation in glioma. Xie Z; Li J; Zhang Y; Zhou R; Zhang H; Duan C; Liu S; Niu L; Zhao J; Liu Y; Song S; Liu X Front Neurosci; 2022; 16():1099019. PubMed ID: 36711137 [TBL] [Abstract][Full Text] [Related]
10. Noninvasive Assessment of O(6)-Methylguanine-DNA Methyltransferase Promoter Methylation Status in World Health Organization Grade II-IV Glioma Using Histogram Analysis of Inflow-Based Vascular-Space-Occupancy Combined with Structural Magnetic Resonance Imaging. He W; Li X; Hua J; Liao S; Guo L; Xiao X; Liu X; Zhou J; Wang W; Xu Y; Wu Y J Magn Reson Imaging; 2021 Jul; 54(1):227-236. PubMed ID: 33590929 [TBL] [Abstract][Full Text] [Related]
11. Arterial spin labeling perfusion-weighted imaging aids in prediction of molecular biomarkers and survival in glioblastomas. Yoo RE; Yun TJ; Hwang I; Hong EK; Kang KM; Choi SH; Park CK; Won JK; Kim JH; Sohn CH Eur Radiol; 2020 Feb; 30(2):1202-1211. PubMed ID: 31468161 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of O6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation and isocitrate dehydrogenase-1 (IDH-1) mutation in glioblastoma multiforme patients: A single-center experience in the Middle East region. Ayoub Z; Geara F; Najjar M; Comair Y; Khoueiry-Zgheib N; Khoueiry P; Mahfouz R; Boulos FI; Kamar FG; Andraos T; Saadeh F; Kreidieh F; Abboud M; Skaf G; Assi HI Clin Neurol Neurosurg; 2019 Jul; 182():92-97. PubMed ID: 31108342 [TBL] [Abstract][Full Text] [Related]
13. Differentiating between glioblastomas with and without isocitrate dehydrogenase gene mutation by findings on conventional magnetic resonance images. Shimizu T; Matsushima S; Fukasawa N; Akasaki Y; Mori R; Ojiri H J Clin Neurosci; 2020 Jun; 76():140-144. PubMed ID: 32291242 [TBL] [Abstract][Full Text] [Related]